Bir Shyamal C, Maiti Tanmoy Kumar, Bollam Papireddy, Nanda Anil
Department of Neurosurgery, LSU Health-Shreveport, Shreveport, Louisiana, United States.
J Neurol Surg B Skull Base. 2016 Feb;77(1):47-53. doi: 10.1055/s-0035-1558834. Epub 2015 Aug 3.
Objective Petroclival meningioma (PM) presents with trigeminal neuralgia (TN) in < 5% of cases. Neurosurgeons often face the dilemma of formulating a treatment protocol when TN recurs. In this study, we sought to set up a protocol in patients with PM who had a recurrent TN. Materials and Methods We performed a retrospective review of 57 patients with PM. Of the 57 patients, only 7 patients presented with TN, and six patients experienced recurrent TN. The study population was evaluated clinically and radiographically after treatment. Results Overall improvement of pain control after various treatments was 67%, and tumor control was 100%. The pain-free period was 2 years for the Gamma Knife radiosurgery (GKRS) group and 4 years for the resection group when treated as a primary treatment (p = 0.034). Of the six patients, four patients had Barrow Neurosurgical Institute (BNI) score I (no TN, no medication), and two patients had BNI score III (some pain controlled with medication). The Karnofsky performance scale score was significantly improved after treatment compared with the pretreated status (78 versus 88; p = 0.044). Conclusion Microsurgical resection is superior to GKRS in achieving and maintaining pain-free status in patients with recurrent trigeminal pain associated with PM.
岩斜区脑膜瘤(PM)患者中出现三叉神经痛(TN)的病例不到5%。当TN复发时,神经外科医生常常面临制定治疗方案的两难境地。在本研究中,我们试图为患有复发性TN的PM患者制定一个治疗方案。材料与方法:我们对57例PM患者进行了回顾性研究。在这57例患者中,只有7例出现TN,其中6例经历了TN复发。对研究人群在治疗后进行了临床和影像学评估。结果:各种治疗后疼痛控制的总体改善率为67%,肿瘤控制率为100%。当作为初始治疗时,伽玛刀放射外科治疗(GKRS)组的无痛期为2年,切除组为4年(p = 0.034)。在这6例患者中,4例患者的巴罗神经外科研究所(BNI)评分为I级(无TN,无需药物治疗),2例患者的BNI评分为III级(部分疼痛通过药物控制)。与治疗前状态相比,治疗后卡氏功能状态评分显著提高(78对88;p = 0.044)。结论:在实现和维持与PM相关的复发性三叉神经痛患者的无痛状态方面,显微手术切除优于GKRS。